BBS-Bioactive Bone Substitutes Oyj

HLSE:BONEH Stock Report

Market Cap: €1.7m

BBS-Bioactive Bone Substitutes Oyj Management

Management criteria checks 1/4

We currently do not have sufficient information about the CEO.

Key information

Juliusz Rakowskias

Chief executive officer

n/a

Total compensation

CEO salary percentagen/a
CEO tenure1.2yrs
CEO ownershipn/a
Management average tenure1.2yrs
Board average tenure4.4yrs

Recent management updates

Recent updates

We Think BBS-Bioactive Bone Substitutes Oyj (HEL:BONEH) Has A Fair Chunk Of Debt

Sep 16
We Think BBS-Bioactive Bone Substitutes Oyj (HEL:BONEH) Has A Fair Chunk Of Debt

BBS-Bioactive Bone Substitutes Oyj (HEL:BONEH) Is Making Moderate Use Of Debt

Dec 20
BBS-Bioactive Bone Substitutes Oyj (HEL:BONEH) Is Making Moderate Use Of Debt

BBS-Bioactive Bone Substitutes Oyj (HEL:BONEH) Is Making Moderate Use Of Debt

Sep 02
BBS-Bioactive Bone Substitutes Oyj (HEL:BONEH) Is Making Moderate Use Of Debt

Is BBS-Bioactive Bone Substitutes Oyj (HEL:BONEH) Using Too Much Debt?

Feb 27
Is BBS-Bioactive Bone Substitutes Oyj (HEL:BONEH) Using Too Much Debt?

CEO

Juliusz Rakowskias

1.2yrs

Tenure

Mr. Juliusz Rakowskias is Chief Executive Officer of BBS-Bioactive Bone Substitutes Oyj from November 03, 2023. He brings a strong track record of leadership and a deep understanding of product sales proce...

Leadership Team

NamePositionTenureCompensationOwnership
Juliusz Rakowskias
Chief Executive Officer1.2yrsno datano data
Annastiina Kauppinen
Financial managerless than a yearno datano data
Paul Watkins
Chief Commercial Officer & Member of Advisory Board5.7yrsno datano data

1.2yrs

Average Tenure

Experienced Management: BONEH's management team is not considered experienced ( 1.2 years average tenure), which suggests a new team.

Board Members

NamePositionTenureCompensationOwnership
Paul Watkins
Chief Commercial Officer & Member of Advisory Boardno datano datano data
Jarmo Halonen
Independent Director8.7yrsno datano data
Kirk Andriano
Independent Director3.8yrsno datano data
Pekka Jalovaara
Chairman of the Board22yrsno data2.61%
€ 44.9k
Brent Atkinsson
Member of Advisory Boardno datano datano data
Declan Flaherty
Member of Advisory Boardno datano datano data
Juhana Leppilahti
Member of Advisory Boardno datano datano data
Timo Jämsä
Member of Advisory Boardno datano datano data
Seppo Nevalainen
Independent Director4.4yrsno datano data
Gregor Siebert
Independent Directorless than a yearno datano data

4.4yrs

Average Tenure

68yo

Average Age

Experienced Board: BONEH's board of directors are considered experienced (4.4 years average tenure).

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/01/02 23:55
End of Day Share Price 2025/01/02 00:00
Earnings2024/06/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

BBS-Bioactive Bone Substitutes Oyj is covered by 2 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Marianne PalmuInderes Oy
Antti SiltanenInderes Oy